Too Old to Operate28m
Deferring CDK4/6 Inhibitor Treatment in HR-Positive/HER2-Negative Advanced BC May Not Impact HRQOL
The phase 3 SONIA trial showed deferring CDK4/6 inhibitor treatment may not compromise HRQOL in patients with HR-positive/HER2-negative advanced breast cancer.
Too Old to Operate48m
Olaparib Shows Long-Term Benefit in High-Risk BRCA1/2-Mutated Breast Cancer
Olaparib improved invasive disease-free survival, distant disease-free survival, and overall survival in high-risk ...